相关实验视频

Updated: Jul 18, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

帕普抑制剂和放射治疗:前列腺癌的新组合 (系统性审查)

Inés Rivero Belenchón^1,2, Carmen Belen Congregado Ruiz^1,2, Carmen Saez²

¹Urology and Nephrology Department, University Hospital Virgen del Rocío, 41013 Seville, Spain.

International journal of molecular sciences

|August 26, 2023

概括

多 (ADP-ribose) 聚合酶抑制剂 (PARPi) 与放射治疗相结合,通过阻碍DNA修复来增强癌细胞的杀死. 本综述检查了PARPi和放射治疗在前列腺癌中的疗效,强调了当前的证据和未来的方向.

科学领域:

在瘤学瘤学.
辐射瘤学辐射瘤学
分子生物学分子生物学

背景情况:

电离辐射诱导DNA损伤,激活细胞修复通路,如NHEJ,HR和BER.
多 (ADP-ribose) 聚合酶抑制剂 (PARPi) 可以通过干扰DNA修复机制,特别是BER来作为放射敏感剂.
这种干扰增加了DNA损伤和细胞死亡,使PARPi成为一个有前途的放射敏感剂.

研究的目的:

审查目前关于PARPi和放射治疗 (RT) 在前列腺癌 (PCa) 联合使用的证据.
为了为PCa治疗的癌症治疗策略提供未来的见解.

主要方法:

临床前和临床研究的文献综述.
分析PARPi和RT组合疗法的机制性理由.
评估前列腺癌的疗效和安全性数据.

主要成果:

在各种瘤中,PARPi和RT的组合显示了放射敏感化作用.
前列腺癌的证据主要来自临床前研究,目前正在进行临床试验.
组合疗法显示出作为一种强有力的瘤战略的潜力.

结论:

PARPi和放射治疗的结合是前列腺癌治疗的有希望的策略.
需要进一步的临床研究来确定其在PCa管理中的作用.
了解PARPi,RT和DNA修复途径之间的相互作用对于优化治疗结果至关重要.

关键词:

这是一种PARP抑制剂.前列腺癌是前列腺癌.辐射疗法辐射疗法

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...